| Syndecans: new kids on the signaling block E Tkachenko, JM Rhodes, M Simons Circulation research 96 (5), 488-500, 2005 | 594 | 2005 |
| The extracellular matrix and blood vessel formation: not just a scaffold JM Rhodes, M Simons Journal of cellular and molecular medicine 11 (2), 176-205, 2007 | 291 | 2007 |
| Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling N Baeyens, MJ Mulligan-Kehoe, F Corti, DD Simon, TD Ross, JM Rhodes, ... Proceedings of the National Academy of Sciences 111 (48), 17308-17313, 2014 | 180 | 2014 |
| Suppression of RhoG activity is mediated by a syndecan 4–synectin–RhoGDI1 complex and is reversed by PKCα in a Rac1 activation pathway A Elfenbein, JM Rhodes, J Meller, MA Schwartz, M Matsuda, M Simons Journal of Cell Biology 186 (1), 75-83, 2009 | 115 | 2009 |
| Regulation of Notch signaling by Drosophila heparan sulfate 3-O sulfotransferase K Kamimura, JM Rhodes, R Ueda, M McNeely, D Shukla, K Kimata, ... The Journal of cell biology 166 (7), 1069-1079, 2004 | 107 | 2004 |
| N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization F Corti, Y Wang, JM Rhodes, D Atri, S Archer-Hartmann, J Zhang, ... Nature communications 10 (1), 1562, 2019 | 71 | 2019 |
| The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues R Lawrence, T Yabe, S HajMohammadi, J Rhodes, M McNeely, J Liu, ... Matrix biology 26 (6), 442-455, 2007 | 56 | 2007 |
| Expression of Blood Group Lewis b Determinant from Lewis a: Association of this Novel. alpha.(1, 2)-L-Fucosylating Activity with the Lewis Type. alpha.(1, 3/4)-L-Fucosyltransferase EV Chandrasekaran, RK Jain, JM Rhodes, CA Srnka, RD Larsen, ... Biochemistry 34 (14), 4748-4756, 1995 | 29 | 1995 |
| Synectin/syndecan‐4 regulate coronary arteriolar growth during development EI Dedkov, MT Thomas, M Sonka, F Yang, TW Chittenden, JM Rhodes, ... Developmental dynamics: An official publication of the American Association …, 2007 | 27 | 2007 |
| Characterization of distinct Gal: 3-O-sulfotransferase activities in human tumor epithelial cell lines and of calf lymph node GlcNAc: 6-O-sulfotransferase activity EV Chandrasekaran, RK Jain, JM Rhodes, R Chawda, C Piskorz, ... Glycoconjugate Journal 16, 523-536, 1999 | 22 | 1999 |
| Challenging the surgical rodent hindlimb ischemia model with the miniinterventional technique ZW Zhuang, J Shi, JM Rhodes, MJ Tsapakos, M Simons Journal of Vascular and Interventional Radiology 22 (10), 1437-1446, 2011 | 19 | 2011 |
| The binding characteristics and utilization of Aleuria aurantia, Lens culinaris and few other lectins in the elucidation of fucosyltransferase activities resembling cloned FT … EV Chandrasekaran, R Chawda, JM Rhodes, RD Locke, CF Piskorz, ... Carbohydrate research 338 (9), 887-901, 2003 | 19 | 2003 |
| A Biosynthetic Control on Structures Serving as Ligands for Selectins: The Precursor Structures, 3-Sialyl/Sulfo Galβ1, 3/4GlcNAcβ-0-R, Which Are High Affinity Substrates for α1 … EV Chandrasekaran, JM Rhodes, RK Jain, RJ Bernacki, KL Matta Biochemical and biophysical research communications 201 (1), 78-89, 1994 | 14 | 1994 |
| Human lung adenocarcinoma α1, 3/4-L-fucosyltransferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 … EV Chandrasekaran, R Chawda, JM Rhodes, J Xia, C Piskorz, KL Matta Glycobiology 11 (5), 353-363, 2001 | 9 | 2001 |
| Publisher Correction: N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent … F Corti, Y Wang, JM Rhodes, D Atri, S Archer-Hartmann, J Zhang, ... Nature Communications 10 (1), 2124, 2019 | 3 | 2019 |
| Tandem mass spectrometric analysis of heparan sulfate structure in the trigeminal ganglion and in a genetic cell model demonstrating the importance of N-deacetylase/N … R Lawrence, T Yabe, S HajMohammadi, J Rhodes, M McNeely, ... GLYCOBIOLOGY 15 (11), 1225-1226, 2005 | | 2005 |
| Mice with reduced anticoagulant herparan sulfate do not exhibit compensatory expressin of 3-0-sulfotransferase-5 S Hajmohammadi, JM Rhodes, W Kett, RA Fava, NW Shworak CIRCULATION 110 (17), 114-114, 2004 | | 2004 |
| Disruption of synectin gene expression stimulates endothelial cell adhesion while inhibiting FGF2-dependent cell growth, migration, and tube branching TW Chittenden, MJ Mulligan-Kehoe, A Lanahan, JM Rhodes, M Simons CIRCULATION 110 (17), 218-218, 2004 | | 2004 |
| Anticoagulant heparan sulfate is preferentially generated by only two members of the 3-OST multigene family JM Rhodes, NW Shworak, T Yabe, P Seeberger, J Liu, RD Rosenberg, ... CIRCULATION 106 (19), 39-39, 2002 | | 2002 |
| Brain specific 30ST isoforms facilitate cellular entry of herpes virus I T Yabe, JM Rhodes, S Hajmohammadi, D Shukla, J Liu, PG Spear, ... GLYCOBIOLOGY 12 (10), 644-644, 2002 | | 2002 |
